Quentin Tavernier
About Quentin Tavernier
Quentin Tavernier is a Medical Science Manager in Innovative Medicine Neuroscience at Bristol Myers Squibb, with a background in Molecular Biology and extensive academic and professional experience.
Title at Bristol Myers Squibb
Quentin Tavernier currently holds the position of Medical Science Manager - Innovative Medicine Neuroscience at Bristol Myers Squibb. He joined the company in this role in October 2020.
Previous Role at Bristol Myers Squibb
Before becoming a Medical Science Manager, Quentin Tavernier served as an assistant chef de projet médical cardiologie at Bristol Myers Squibb from 2019 to 2020 for a year.
PhD and Teaching Experience
Quentin Tavernier completed his Doctor of Philosophy (PhD) in Molecular Biology at Université Paris Descartes, where he also worked as a PhD Graduate Student in Inserm UMRS 1147 from 2015 to 2018 for three years. During this period, he also taught Biochemistry at the university.
Educational Background in Project Management and Entrepreneurship
Quentin Tavernier completed his Master of Business Administration (MBA) in Management de projet from MBA ESG between 2019 and 2020. Additionally, he studied Entrepreneurship at ESCP Europe in 2017 for eleven months.
Advanced Degrees in Science and Toxicology
Quentin Tavernier earned a Master 2 in Human Toxicology, Risk Assessment, and Vigilance from Université Paris Descartes from 2013 to 2014. He also holds a Master 1 in Biology/Pharmaco-toxicology from Université René Descartes (Paris V) for the academic year 2012-2013.
Undergraduate Degree in Biological and Biomedical Sciences
Quentin Tavernier achieved a license in Biological and Biomedical Sciences from Université René Descartes (Paris V) where he studied from 2010 to 2012.